BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 11812188)

  • 1. Rationale for clinical trials of selenium as an antioxidant for the treatment of the cardiomyopathy of Friedreich's ataxia.
    Fryer MJ
    Med Hypotheses; 2002 Feb; 58(2):127-32. PubMed ID: 11812188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac transplantation: a temporary solution for Friedreich's ataxia-induced dilated cardiomyopathy.
    Sedlak TL; Chandavimol M; Straatman L
    J Heart Lung Transplant; 2004 Nov; 23(11):1304-6. PubMed ID: 15539131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidants and Friedreich's ataxia.
    Fryer MJ
    Lancet; 1999 Oct; 354(9186):1300-1. PubMed ID: 10520661
    [No Abstract]   [Full Text] [Related]  

  • 4. Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
    Parkinson MH; Schulz JB; Giunti P
    J Neurochem; 2013 Aug; 126 Suppl 1():125-41. PubMed ID: 23859348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilated cardiomyopathy associated with Friedreich's ataxia.
    Steinsapir K; Lewis W
    Arch Pathol Lab Med; 1985 May; 109(5):454-6. PubMed ID: 3838661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia.
    Bunse M; Bit-Avragim N; Riefflin A; Perrot A; Schmidt O; Kreuz FR; Dietz R; Jung WI; Osterziel KJ
    Ann Neurol; 2003 Jan; 53(1):121-3. PubMed ID: 12509856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia.
    Lodi R; Hart PE; Rajagopalan B; Taylor DJ; Crilley JG; Bradley JL; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
    Ann Neurol; 2001 May; 49(5):590-6. PubMed ID: 11357949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permanent use of a ventricle assist device for dilated cardiomyopathy in Friedreich's ataxia.
    Yoda M; El-Banayosy A; Arusoglu L; Tendrich G; Minami K; Körfer R
    J Heart Lung Transplant; 2006 Feb; 25(2):251-2. PubMed ID: 16446231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Friedreich's ataxia cardiomyopathy: case based discussion and management issues.
    Hanley A; Corrigan R; Mohammad S; MacMahon B
    Ir Med J; 2010 Apr; 103(4):117-8. PubMed ID: 20486316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of antioxidants in Friedreich's ataxia treatment.
    Rustin P
    Expert Opin Investig Drugs; 2003 Apr; 12(4):569-75. PubMed ID: 12665413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of hypertrophic into a dilated left ventricle in Friedreich's ataxia.
    Casazza F; Morpurgo M
    G Ital Cardiol; 1988 Jul; 18(7):615-8. PubMed ID: 3234661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Friedreich's ataxia: coenzyme Q10 and vitamin E therapy.
    Cooper JM; Schapira AH
    Mitochondrion; 2007 Jun; 7 Suppl():S127-35. PubMed ID: 17485244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could thiazolidinediones increase the risk of heart failure in Friedreich's ataxia patients?
    García-Giménez JL; Sanchis-Gomar F; Pallardó FV
    Mov Disord; 2011 Apr; 26(5):769-71. PubMed ID: 21469214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
    Cooper JM; Schapira AH
    Biofactors; 2003; 18(1-4):163-71. PubMed ID: 14695932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyopathy in Friedreich's ataxia.
    Rahman F; Pandolfo M
    Acta Neurol Belg; 2011 Sep; 111(3):183-7. PubMed ID: 22141280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two case studies of hypertrophic cardiomyopathy in Friedreich's ataxia].
    Cervantes-Arriaga A; Rodríguez-Violante M; Villar-Velarde A; Vargas-Cañas S
    Gac Med Mex; 2009; 145(4):343-6. PubMed ID: 20073435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium deficiency and fatal cardiomyopathy in a patient on home parenteral nutrition.
    Fleming CR; Lie JT; McCall JT; O'Brien JF; Baillie EE; Thistle JL
    Gastroenterology; 1982 Sep; 83(3):689-93. PubMed ID: 6807740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac manifestations of Friedreich's ataxia].
    Kolek M; Mrózek V; Schenk P
    Cas Lek Cesk; 2004; 143(1):48-51. PubMed ID: 15061120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia.
    Auchère F; Santos R; Planamente S; Lesuisse E; Camadro JM
    Hum Mol Genet; 2008 Sep; 17(18):2790-802. PubMed ID: 18562474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.